Increase of Transforming Growth Factor-Beta 1 in Gingival Crevicular Fluid during Human Orthodontic Tooth Movement
Fuad Lutf Almotareb1, Basheer Hamed Hamood Al-Shameri2, Mohammed Mohammed Ali Al-Najhi3, Omar Ahmed Ismael Al-dossary4 and Hassan Abdulwahab Al-Shamahy4,5
1Orthodontics, Pedodontics and Prevention Department Faculty of Dentistry, Sana'a University, Republic of Yemen
2Department of Restorative and Esthetic Dentistry, Faculty of Dentistry, Sana’a University, Republic of Yemen
3Orthodontics, Pedodontics and Prevention Department Faculty of Dentistry, Genius University for Sciences & Technology, Dhamar city, Republic of Yemen
4Departement of Basic Sciences, Faculty of Dentistry, Sana’a University, Republic of Yemen
5Medical Microbiology Department, Faculty of Medicine, Genius University for Sciences & Technology, Dhamar City, Republic of Yemen
*Corresponding author: Hassan Abdulwahab Al-Shamahy, Department of Basic Sciences, Faculty of Dentistry, Sana’a University, Republic of Yemen; Medical Microbiology Department, Faculty of Medicine, Genius University for Sciences & Technology, Dhamar City, Republic of Yemen.
Citation: Almotareb FL, Al-Shameri BHH, Al-Najhi MMA, Al-dossary OAI, Al-Shamahy HA. (2023) Increase of Transforming Growth Factor-Beta 1 in Gingival Crevicular Fluid during Human Orthodontic Tooth Movement. J Oral Med and Dent Res. 4(2):1-09.
Received: September 07, 2023 | Published: September 21, 2023
Copyright©2023 by Almotareb FL, et al. All rights reserved. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
DOI: http://doi.org/10.52793/JOMDR.2023.4(2)-43
Abstract
In this study, transforming growth factor-beta 1 (TGF-beta 1) was located and measured in human gingival crevicular fluid, and alterations during orthodontic tooth movement were investigated. A total of 87 patients, with a mean age of 19.58, participated. The central incisor of each patient getting one treatment for distal migration served as the experimental tooth. Before activation as well as after 7, 21, and 90 days after the onset of tooth movement in the experimental teeth, gingival crevicular fluid from each participant was taken. TGF-beta 1 was recognized utilizing an enzyme-linked immunosorbent assay. In the experimental teeth at 7 and 21 and 90 days compared to the baseline, which was before orthodontic therapy was performed, TGF- -beta 1 concentration was significantly greater. Additionally, TGF-beta 1 levels in the gingival crevicular fluid were influenced by patient factors like age and sex. The use of A-wire and power elastic has an impact on TGF-beta 1, with power elastic having a greater effect than A-wire on TGF-beta 1 levels in GCF. According to these findings, TGF-beta 1 is likely involved in the remodeling of bone that occurs during orthodontic tooth movement.
Keywords
Human gingival crevicular fluid (HGCF); Orthodontic tooth movement; Transforming growth factor-beta 1 (TGF-beta 1)
Introduction
The quality of a person's life is greatly impacted by malocclusion. Yemen ranks third after caries and periodontal disease in terms of malocclusion prevalence, at almost 80% [1-4]. Orthodontic demands in the community have grown in demand along with the advancement of knowledge society and the desire to enhance quality of life. Orthodontic therapy aimed to correct jaw alignment issues and dental abnormalities. Through tissue remodeling, it makes use of the ability of the periodontal ligament and the alveolar bone to adjust to shifting mechanical conditions [5-8]. These adaptations allow for the movement of teeth through the alveolar bone as well as the influence on distant skeletal regions. These two methods can be used to provide a stable occlusion and a healthy jaw relationship [9]. Orthodontic tooth movement is achieved through mechanical pressure remodeling of the alveolar bone and periodontal ligament. The activation of many markers for bone remodeling mediates this remodeling. Numerous researches were conducted to provide us with more details regarding this molecular signaling, including those on TIMP-1, Col-1, RANKL, IL-6, sgp-130, and others [10–14]. Transforming growth factor (TGF-), one of the growth factors, is yet unknown in terms of its function in tooth mobility during orthodontic treatment. Others discovered it may help to induce bone resorption [17,18], whereas some authors identified it to be a mediator for decreased osteoclast activity [8,15,16]. There are three distinct isoforms of TGF: TGF-β1, TGF-β2, and TGF-β3. An osteoporosis-like phenotype was discovered to be caused by excessive TGF-1 expression [19]. Given that TGF-β1 plays a role in bone remodeling, the objective of this study was to look at how TGF-β1 levels changed as a result of mechanical stress during orthodontic tooth movement. This fluctuating level of TGF-β1 was examined soon before the application of mechanical load, 7 days, 21 days, and 90 days after the mechanical load.
Materials and Methods
The study focused on patients who had received fixed orthodontic appliances in clinics run by the orthodontic department of Sana'a University's dental faculty and the Azal dental center in Sana'a city. Data on demographics and those related to fundamental management were gathered. Additionally, an intra-oral examination, dentition evaluation, oral hygiene evaluation, and medical history evaluation were completed.
Study Design: This study compares the levels of pro-inflammatory (TGF- β1) cytokines in gingival crevicular fluid (GCF), and host and material factors may have an impact on these levels in addition to the effect of orthodontic treatment. It is a longitudinal prospective clinical randomized chosen cohort study.
Inclusion Criteria: Yemeni female or male, 13 to 35 years old, free of any obvious genetic disorders or dental anomalies, seemingly healthy, not pregnant, not smoking, not chewing khat, and free of any systemic or chronic diseases, diagnosed as being eligible for treatment with fixed orthodontic appliances, and not having received antibiotics, corticosteroid therapy, or anti-inflammatory drugs within the past month.
Gingival Crevicular Fluids (GCF) Collection for Cytokine Detection: Subjects were instructed beforehand that they should refrain from eating, drinking, chewing gum, or brushing their teeth for an hour before to sample collection. Sterile Paper-points strips (PAPER POINTS DIA-PROT, DiaDent Group, Choongchong Buk Do Republic of Korea) were inserted into the gingival fissure of the teeth and held there until a slight resistance was felt to collect gingival crevicular fluid. To avoid salivary contamination, sampling was limited to the gingival crevice of the tooth. dentist plaque was cleaned using cotton, and the tooth surfaces were dried using an air syringe attached to the dentist chair. Gently inserting paper-point strips into the sulcus with caution to prevent mechanical damage and bleeding, the strips were left in situ for 30 seconds to absorb the gingival fluids, and the gingival crevicular fluids were collected. Because contamination of strips with blood or saliva is significant and can lead to inaccurate results, contaminated samples were removed from the study. All gingival crevicular fluid samples were obtained in pre-labeled sterile Eppendorf tubes with 1.5 ml volumes from CITOTEST in China, which were then stored at -35 oC for ensuing testing and analysis.
Finding and Measuring Pro-Inflammatory (TGF- β1) Cytokines: To help with the elution of cytokines from each filter paper, each strip was eluted into 200 l of sterile Phosphate Buffered Saline PBS (pH 7.4). The samples were centrifuged at 1000 g for 20 minutes before the experiment was started. Following the instructions of the manufacturer (Wuhan Fine Biotech Co., Ltd. Wuhan, Hubei, China), the enzyme-linked immunosorbent assay (ELISA) was used to measure the concentration of the pro-inflammatory (TGF- β1) mediators present in the GCF.
Data Analysis: Epi-info (version 7) was used to enter and evaluate the data. The mean and standard deviation (SD) for the amounts of TGF- β1 during several time periods of GCF collection were used to express the data for this protein, which had a normal distribution. This method calculates the variance between the means found in two distinct samples. The difference between the mean of the reference (baseline) TGF- β1± SD and the mean of the TGF- β1 levels in GCF at 7, 21, and 90 days were calculated.
Ethical Consideration: Sana'a University's Faculty of Medicine and Health Sciences' Medical Ethics and Research Committee granted this study No. 699, dated January 24, 2021, their approval in accordance with medical ethics. The review committee's ethical standards were followed in all procedures.
Results
The levels of TGF-β-1 in human gums during orthodontic treatment were determined in 87 patients; 33 (37.9%) males, 54 (62.1%) females, and their ages ranged from 12 to 34 years, with a mean ± SD equal to 19.58 ± 4.4 years. TGF-β-1 levels differed from each other at different treatment periods as measures of TGF-β-1 central tendency was elevated after orthodontic treatment was applied. Whereas, the mean ± SD for TGF-β-1 increased from 47.83 ± 4.83 pg/mL at baseline to 50.5 ± 5.8 pg/mL after 7 days, to 52.3 ± 6.2 pg/mL after 21 days, and then slightly rise to 52.8 ± 7.1pg/mLl 90 days after orthodontic treatment (Table 1). Considering of sex in TGF-β-1 levels at different treatment periods as measures of TGF-β-1 were elevated in female patients comparing to male patients after orthodontic treatment was applied. Whereas, the mean ± SD for TGF-β-1 increased in females from 47.83 ± 4.83 pg/mL at baseline to 52.8 ± 6 pg/mL after 7 days, then decrease to 49.9 ± 4.9 pg/mL after 21 days, and then rise to 55.5 ± 7.4pg/mLl 90 days after orthodontic treatment, while male patients had lower values than these values (Table 1). Considering of age groups the TGF-β-1 levels at different treatment periods as were very low at the base line for <16 years group (26.83 ± 4.29 pg/mL) then sudden rise to 39.68 ± 10.74 pg/mL at after 7 days of applying orthodontic treatment, continue rise to 42.37 ± 10.81 pg/mL after 21 days, and then decrease to 32.43 ± 5.64pg/mL in 90 days after orthodontic treatment, while older age group (26-34 years) patients had higher values in the base line (37.27 ± 4.98 pg/mL ). The highest value was recorded after 90 days of orthodontic treatment (54.84± 11.92 pg/mL) for this age group (Table 1).
Characteristics |
Number |
(%) |
Gender |
||
Male |
33 |
37.9 |
Female |
54 |
62.1 |
Age groups in Years |
||
<16 |
16 |
18.4 |
16 -25 |
62 |
71.3 |
26 -34 |
9 |
10.3 |
Total |
87 |
100 |
Mean |
19.58 years |
- |
SD |
4.4 years |
|
Mode |
17 years |
|
Median |
18 years |
|
Minimum -Maximum |
12-34 years |
Table 1: Characteristics of patients, tested for TGF-β-1 Levels in the Human Gingival Sulcus during Orthodontic Treatment.
Regarding the impact of the wire types used in orthodontic treatment, patients who used A wire had greater TGF- β -1 levels than those who used power elastic (54.5 ±7.4 pg/mL in the 90 days following treatment against 52± 6.5 pg/mL in the same period for power elastic-using patients). Additionally, in each of the three intervals, A wire patient values were higher than power elastic patient values (Table 2). Given the impact of gum bleeding following orthodontic treatment, there were greater TGF- β-1 levels in individuals with bleeding compared to non-bleeding patients (55.9 ±11.28 pg/mL vs. 44.65± 9.42 pg/mL after 21 days). Additionally, in the three intervals following orthodontic treatment, all bleeding patient values were higher than those of non-bleeding patients (Table 2).
- |
Baseline |
7 d |
21 d |
90 d |
Baseline |
7 d |
21 d |
90 d |
Baseline |
7 d |
21 d |
90 d |
Characters |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Sex |
Total n=87 |
- |
- |
- |
Males n=33 |
- |
- |
- |
Female n=54 |
- |
- |
- |
Mean |
47.83 |
51 |
52 |
52.8 |
47.9 |
50 |
48 |
52 |
47.9 |
52.8 |
50 |
56 |
SD |
5.2 |
5.8 |
6 |
7.1 |
5.7 |
5.7 |
5.7 |
6.5 |
4.9 |
6 |
5 |
7 |
Type of wire |
Total n= 87 |
- |
- |
- |
Power elastic n= 39 |
- |
- |
- |
A wire n= 63 |
- |
- |
- |
Mean |
47.83 |
51 |
52 |
52.8 |
47.9 |
50 |
48 |
52 |
47.9 |
51.8 |
52 |
55 |
SD |
5.2 |
5.8 |
6 |
7.1 |
5.7 |
5.7 |
5.7 |
6.5 |
4.9 |
6 |
5 |
7 |
Age groups |
< 16 years group n=16 |
- |
- |
- |
16-25 years n=62 |
- |
- |
- |
26-34 years n=10 |
- |
- |
- |
Mean |
26.83 |
40 |
42 |
32.4 |
32.43 |
33 |
43 |
45 |
37.3 |
33.77 |
52 |
54..84 |
SD |
4.29 |
11 |
11 |
5.64 |
5.64 |
4.1 |
8.6 |
9.6 |
4.98 |
3.96 |
11 |
12 |
Gam bleeding |
Total n=87 |
- |
- |
- |
Bleeding n=12 |
- |
- |
- |
Non-bleeding |
- |
- |
- |
Mean |
47.83 |
51 |
52 |
52.8 |
35.42 |
54 |
56 |
41 |
31.7 |
41.93 |
45 |
36 |
SD |
5.2 |
5.8 |
6 |
7.1 |
4.64 |
13 |
11 |
6.9 |
4.67 |
8.79 |
9 |
5 |
Discussion
Conclusion
Acknowledgments
Conflict of Interest
Author’s Contributions
References